OncoZenge AB (publ) (ONCOZ.ST)

SEK 3.97

(4.34%)

Revenue Summary of OncoZenge AB (publ)

  • OncoZenge AB (publ)'s latest annual revenue in 2023 was 3000.00 SEK , down 0.0% from previous year.
  • OncoZenge AB (publ)'s latest quarterly revenue in 2024 Q2 was 1000.00 SEK , down 0.0% from previous quarter.
  • OncoZenge AB (publ) reported a annual revenue of - SEK in annual revenue 2022, down 0.0% from previous year.
  • OncoZenge AB (publ) reported a annual revenue of - SEK in annual revenue 2021, down 0.0% from previous year.
  • OncoZenge AB (publ) reported a quarterly revenue of 1000.00 SEK for 2024 Q2, down 0.0% from previous quarter.
  • OncoZenge AB (publ) reported a quarterly revenue of - SEK for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of OncoZenge AB (publ) (2023 - 2020)

Historical Annual Revenue of OncoZenge AB (publ) (2023 - 2020)

Year Revenue Revenue Growth
2023 3000.00 SEK 0.0%
2022 - SEK 0.0%
2021 - SEK 0.0%
2020 - SEK 0.0%

Peer Revenue Comparison of OncoZenge AB (publ)

Name Revenue Revenue Difference
Alligator Bioscience AB (publ) 58.1 Million SEK 99.995%
Ziccum AB (publ) 3.74 Million SEK 99.92%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 615.99 Million SEK 100.0%
Sprint Bioscience AB (publ) 50.48 Million SEK 99.994%
Mendus AB (publ) 28.48 Million SEK 99.989%
Genovis AB (publ.) 158.23 Million SEK 99.998%
Intervacc AB (publ) 8.01 Million SEK 99.963%
QuiaPEG Pharmaceuticals Holding AB (publ) 4.37 Million SEK 99.931%
Active Biotech AB (publ) - SEK -Infinity%
Magle Chemoswed Holding AB (publ) 170.44 Million SEK 99.998%
Bio-Works Technologies AB (publ) 43.89 Million SEK 99.993%
Aptahem AB (publ) 2.63 Million SEK 99.886%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) 1.03 Million SEK 99.71%
Infant Bacterial Therapeutics AB (publ) 77 Thousand SEK 96.104%
Fluicell AB (publ) 3.33 Million SEK 99.91%
Saniona AB (publ) 16.84 Million SEK 99.982%
Lipigon Pharmaceuticals AB (publ) 16.4 Million SEK 99.982%
Biovica International AB (publ) 7.29 Million SEK 99.959%
Spago Nanomedical AB (publ) 1.2 Million SEK 99.751%
AcouSort AB (publ) 10.55 Million SEK 99.972%
Xintela AB (publ) 78 Thousand SEK 96.154%
Abliva AB (publ) 137 Thousand SEK 97.81%
Egetis Therapeutics AB (publ) 57.6 Million SEK 99.995%
Karolinska Development AB (publ) 2.01 Million SEK 99.851%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) 155 Thousand SEK 98.065%
CombiGene AB (publ) 5.54 Million SEK 99.946%
Asarina Pharma AB (publ) - SEK -Infinity%
Calliditas Therapeutics AB (publ) 1.2 Billion SEK 100.0%
Camurus AB (publ) 1.71 Billion SEK 100.0%
Corline Biomedical AB 25.03 Million SEK 99.988%
IRLAB Therapeutics AB (publ) 5.67 Million SEK 99.947%
Isofol Medical AB (publ) 721 Thousand SEK 99.584%
I-Tech AB 120.86 Million SEK 99.998%
Hansa Biopharma AB (publ) 134.09 Million SEK 99.998%
Cyxone AB (publ) 5.14 Million SEK 99.942%
ExpreS2ion Biotech Holding AB (publ) 7.05 Million SEK 99.957%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB 10.66 Million SEK 99.972%
Xspray Pharma AB (publ) - SEK -Infinity%
Elicera Therapeutics AB (publ) 11.23 Million SEK 99.973%
Nanologica AB (publ) 1.44 Million SEK 99.792%
SynAct Pharma AB - SEK -Infinity%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) - SEK -Infinity%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 53 Thousand SEK 94.34%
BioInvent International AB (publ) 71.46 Million SEK 99.996%
Alzinova AB (publ) 270 Thousand SEK 98.889%
Oncopeptides AB (publ) 35.22 Million SEK 99.991%
Pila Pharma AB (publ) 1.46 Million SEK 99.795%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) 2.82 Million SEK 99.894%
Simris Alg AB (publ) 4.35 Million SEK 99.931%
Diamyd Medical AB (publ) 130 Thousand SEK 97.692%
Xbrane Biopharma AB (publ) 238.72 Million SEK 99.999%
Ascelia Pharma AB (publ) - SEK -Infinity%
Diagonal Bio AB (publ) 23 Thousand SEK 86.957%